The relation between immunoglobulin G antibodies to Chlamydia trachomatis and poor ovarian response to gonadotropin stimulation before in vitro fertilization

Fertil Steril. 1998 Aug;70(2):214-8. doi: 10.1016/s0015-0282(98)00145-9.

Abstract

Objective: To determine whether a relation exists between previous exposure to Chlamydia trachomatis and impaired ovarian response to gonadotropin stimulation.

Design: Controlled clinical study.

Setting: Two university IVF centers.

Patient(s): Two hundred forty-two patients receiving IVF treatment and 81 control patients. Ninety-four patients with a poor response to IVF, defined by cycle cancellation in response to a daily stimulation dose of 300 IU of FSH, and 148 patients with a good response were matched for age. Twenty-eight pregnant controls and 53 controls of proven fertility also were included.

Intervention(s): Serum samples were obtained from patients and controls. Serum levels of immunoglobulin (Ig) G antibodies to C. trachomatis were determined by ELISA.

Main outcome measure(s): The prevalence of serum IgG antibodies to C. trachomatis in critically defined poor responders was compared with that of age-matched good responders.

Result(s): A significantly higher proportion of poor responders had serum IgG antibodies to C. trachomatis compared with good responders (44.7% and 30.4%, respectively). Patients undergoing IVF had a significantly higher prevalence of IgG antibodies to C. trachomatis (36%) than did either pregnant or nonpregnant controls (12%).

Conclusion(s): A significantly higher prevalence of serum IgG antibodies to C. trachomatis was observed in critically defined poor responders, suggesting a possible detrimental effect of C. trachomatis on subsequent ovarian function.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Multicenter Study

MeSH terms

  • Adult
  • Antibodies, Bacterial / blood*
  • Chlamydia trachomatis / immunology*
  • Female
  • Fertilization in Vitro*
  • Humans
  • Immunoglobulin G / blood*
  • Menotropins / therapeutic use*
  • Ovary / drug effects*
  • Ovary / immunology
  • Pregnancy
  • Stimulation, Chemical
  • Treatment Outcome

Substances

  • Antibodies, Bacterial
  • Immunoglobulin G
  • Menotropins